FBRX - Forte Biosciences GAAP EPS of -$0.21 August, 15 2022 05:03 PM Forte Biosciences Inc. Forte Biosciences press release ( NASDAQ: FBRX ): GAAP EPS of -$0.21. Ended second quarter 2022 with approximately $38.5 million in cash and cash equivalents For further details see: Forte Biosciences GAAP EPS of -$0.21